- Home
- ICCC vs CFSB Comparison
ICCC vs CFSB Comparison
Compare ICCC & CFSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- CFSB
- Stock Information
- Founded
- ICCC 1982
- CFSB 1889
- Country
- ICCC United States
- CFSB United States
- Employees
- ICCC N/A
- CFSB N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- CFSB Major Banks
- Sector
- ICCC Health Care
- CFSB Finance
- Exchange
- ICCC Nasdaq
- CFSB Nasdaq
- Market Cap
- ICCC 60.1M
- CFSB 51.6M
- IPO Year
- ICCC 1987
- CFSB N/A
- Fundamental
- Price
- ICCC $5.90
- CFSB $13.90
- Analyst Decision
- ICCC
- CFSB
- Analyst Count
- ICCC 0
- CFSB 0
- Target Price
- ICCC N/A
- CFSB N/A
- AVG Volume (30 Days)
- ICCC 12.6K
- CFSB 1.1K
- Earning Date
- ICCC 08-14-2025
- CFSB 08-26-2025
- Dividend Yield
- ICCC N/A
- CFSB N/A
- EPS Growth
- ICCC N/A
- CFSB N/A
- EPS
- ICCC 0.20
- CFSB N/A
- Revenue
- ICCC $28,274,756.00
- CFSB $7,484,000.00
- Revenue This Year
- ICCC N/A
- CFSB N/A
- Revenue Next Year
- ICCC N/A
- CFSB N/A
- P/E Ratio
- ICCC $30.45
- CFSB N/A
- Revenue Growth
- ICCC 21.75
- CFSB N/A
- 52 Week Low
- ICCC $3.34
- CFSB $6.34
- 52 Week High
- ICCC $7.60
- CFSB $13.98
- Technical
- Relative Strength Index (RSI)
- ICCC 38.90
- CFSB 64.63
- Support Level
- ICCC $5.92
- CFSB $13.86
- Resistance Level
- ICCC $6.90
- CFSB $13.93
- Average True Range (ATR)
- ICCC 0.36
- CFSB 0.02
- MACD
- ICCC -0.05
- CFSB -0.03
- Stochastic Oscillator
- ICCC 0.00
- CFSB 46.67
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.